title: Effect of tiotropium on cough reflex sensitivity in acute viral cough.
abstract: OBJECTIVE
  Cough is the most common complaint for which patients in the United States seek medical attention. Few, if any, effective therapies exist for the most common form of acute cough, that due to viral upper respiratory tract infection (URI). The aim of this study was to evaluate the effect of the anticholinergic agent tiotropium bromide on cough reflex sensitivity in subjects with acute viral URI.
  
  
  METHODS
  Otherwise healthy adult nonsmokers with acute viral URI were randomized to receive inhaled tiotropium, 18 microg once daily, or matched placebo, for 7 days. A control group of healthy volunteers underwent an identical protocol.
  
  
  RESULTS
  Cough reflex sensitivity to inhaled capsaicin was measured at baseline (Day 0), and 1 h after the first (Day 1) and seventh (Day 7) dose of tiotropium or placebo. Concentrations of capsaicin inducing two or more (C (2)) and five or more coughs (C (5)) were determined. In subjects with URI, tiotropium (n = 11) demonstrated inhibition of cough reflex sensitivity relative to baseline (increased log C (2) [p = 0.004] and log C (5) [p = 0.0004]) after the first dose. No change occurred in the placebo group (n = 10). After 7 days, mean log C (2) was significantly increased in the tiotropium group relative to placebo (p = 0.03). Although FEF(25-75) was also increased in the tiotropium group (p = 0.016), there was no significant correlation between changes in cough reflex sensitivity and FEF(25-75). Tiotropium had no effect in healthy volunteers (n = 24).
  
  
  CONCLUSIONS
  Tiotropium inhibits cough reflex sensitivity to capsaicin in subjects with acute viral URI. The antitussive effect of tiotropium may occur through a mechanism other than bronchodilation.
authors.affiliation: Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461, USA. pdicpinigaitis@pol.net
authors.forename: Peter V
authors.initials: PV
authors.lastname: Dicpinigaitis
authors.forename: Leah
authors.initials: L
authors.lastname: Spinner
authors.forename: Ganesha
authors.initials: G
authors.lastname: Santhyadka
authors.forename: Abdissa
authors.initials: A
authors.lastname: Negassa
mesh_terms: D000328:Adult; D000996:Antitussive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002211:Capsaicin / Q000008:administration & dosage; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D003371:Cough / Q000139:chemically induced / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D008297:Male; D011446:Prospective Studies; D012018:Reflex / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012602:Scopolamine Derivatives / Q000008:administration & dosage / Q000494:pharmacology*; D012680:Sensitivity and Specificity; D000069447:Tiotropium Bromide
chemical_list: D000996:Antitussive Agents; D018680:Cholinergic Antagonists; D012602:Scopolamine Derivatives; D002211:Capsaicin; D000069447:Tiotropium Bromide
references.citation: Respir Med. 2007 Nov;101(11):2386-94
references.pmid: 17761412
references.citation: Pulm Pharmacol Ther. 2003;16(1):61-5
references.pmid: 12657501
references.citation: Pharmacol Ther. 2003 Apr;98(1):59-69
references.pmid: 12667888
references.citation: Pulm Pharmacol. 1996 Oct-Dec;9(5-6):293-7
references.pmid: 9232666
references.citation: Am Rev Respir Dis. 1976 Feb;113(2):131-9
references.pmid: 1247226
references.citation: Respir Med. 1996 May;90(5):279-86
references.pmid: 9499812
references.citation: Am J Respir Crit Care Med. 2002 Oct 1;166(7):961-4
references.pmid: 12359654
references.citation: Vital Health Stat 13. 2004 Sep;(157):1-70
references.pmid: 15499797
references.citation: Br J Clin Pharmacol. 1994 Feb;37(2):187-91
references.pmid: 8186064
references.citation: Eur Respir J. 2007 Jun;29(6):1256-76
references.pmid: 17540788
references.citation: Neurogastroenterol Motil. 2007 Jan;19(1):47-56
references.pmid: 17187588
references.citation: Chest. 2006 Jan;129(1 Suppl):1S-23S
references.pmid: 16428686
references.citation: Respir Res. 2006 May 09;7:73
references.pmid: 16684353
references.citation: Cochrane Database Syst Rev. 2004;(1):CD004358
references.pmid: 14974067
references.citation: J Pharm Pharmacol. 1997 Oct;49(10):1045-9
references.pmid: 9364418
references.citation: Thorax. 1990 Sep;45(9):694-8
references.pmid: 2145656
references.citation: Thorax. 1993 Jun;48(6):615-8
references.pmid: 8346491
references.citation: Eur Respir J. 1991 Oct;4(9):1078-9
references.pmid: 1836766
references.citation: Chest. 1998 May;113(5):1319-21
references.pmid: 9596313
references.citation: Respir Med. 1992 Sep;86(5):425-9
references.pmid: 1462022
references.citation: Thorax. 1985 Sep;40(9):662-7
references.pmid: 2932814
references.citation: Thorax. 1992 Jun;47(6):441-5
references.pmid: 1386691
references.citation: J Appl Physiol (1985). 1992 Oct;73(4):1273-81
references.pmid: 1447069
references.citation: Am J Respir Cell Mol Biol. 1989 Sep;1(3):245-50
references.pmid: 2516453